Merz North America, Inc.

Merz North America, Inc. is a family-owned aesthetics company specializing in injectable and energy-based devices for aesthetic medicine. The company markets a portfolio of FDA-approved products for facial rejuvenation, wrinkle correction, and dermal contouring. Primary offerings include XEOMIN® (incobotulinumtoxinA), a botulinum toxin Type A neuromodulator for moderate-to-severe upper facial lines (frown lines, forehead lines, crow's feet); RADIESSE® and RADIESSE® (+), calcium hydroxylapatite dermal fillers for nasolabial folds, facial wrinkles, hand volume restoration, and jawline contouring; BELOTERO BALANCE®, a hyaluronic acid dermal filler for mid-to-deep dermis injection; and the ULTHERA® System, an ultrasound-based energy device for skin lifting and tightening of the neck, chin, eyebrow, and décolleté. The company also offers SaltFacial®, combining ultrasound diathermy and LED phototherapy for acne treatment and dermatological applications. All products carry FDA clearance or approval. Merz serves aesthetic practitioners, dermatologists, and plastic surgeons across the United States. The company provides patient safety information, prescribing guidance, and support through MyMerz Solutions customer service (1-844-469-6379). As of February 2026, XEOMIN® celebrated 15 years of U.S. market presence, and RADIESSE® recently received FDA approval for décolleté wrinkle treatment, reflecting ongoing product line expansion and regulatory advancement.